Last reviewed · How we verify
NCT04838457: ACME-TM
Telehealth Treatment of Veterans With Alcohol Misuse at Risk for Cardiovascular Disease
NA trial testing Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM) in Alcohol Misuse in 30 participants. Participants enrolled and being followed up; not accepting new ones.
30 May 2025
Quick facts
| Lead sponsor | VA Office of Research and Development |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 30 |
| Start date | 1 December 2021 |
| Primary completion | 30 May 2025 |
| Estimated completion | 30 May 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM)
Conditions studied
- Alcohol Misuse — all drugs for Alcohol Misuse →
- Hypertension — all drugs for Hypertension →
- Elevated Cardiovascular Risk — all drugs for Elevated Cardiovascular Risk →
Sponsor
VA Office of Research and Development — full company profile →
Who can join
18 and older, any sex, with Alcohol Misuse or Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this project is to refine a cognitive-behavioral intervention for comorbid alcohol misuse and modifiable CVD risk with diverse stakeholder input, so that the intervention can be deployed within existing VA systems. The intervention will deliver telehealth CBT for alcohol misuse, tailored and timely text messages facilitating clinical traction with CVD risk reduction, and a telehealth coaching call to transition focus of treatment targets. The primary hypotheses of this study are that the developed intervention will be feasible to deliver, acceptable to Veterans and clinicians, and show signs of reducing alcohol misuse and increasing behaviors associated with cardiovascular health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04838457
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Misuse
Currently open trials in the same condition.
- NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
- NCT07132177 — Targeted Naltrexone to Support Individuals Participating in Dry January · Phase 2 · recruiting
- NCT07339150 — MiREA-AC for Reducing Problematic Alcohol and Marijuana Use in College Students · NA · recruiting
- NCT06778278 — Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans · NA · recruiting
- NCT07021053 — Adaptive Actions and Alcohol Use Outcomes During Internet-delivered Cognitive Behaviour Therapy · NA · recruiting
Other VA Office of Research and Development trials
Trials by the same sponsor.
- NCT07456150 — Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care · Phase 1 · not yet recruiting
- NCT06746727 — The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veteran · NA · not yet recruiting
- NCT07362576 — Perinatal Peer Support for Veterans With Serious Mental Illness · NA · not yet recruiting
- NCT06766331 — Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans · NA · not yet recruiting
- NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04838457 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by VA Office of Research and Development
- Last refreshed: 15 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04838457.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing